Medicine deficiency: weight loss under pressure-patients despair!

Medicine deficiency: weight loss under pressure-patients despair!

The hunt for the miracle cures for weight reduction is becoming increasingly chaotic! The popular drugs Wegovy, Ozempic and Mounjaro, which are advertised as "eternal" solutions to combat overweight, are not only difficult to get, but also bring many patients into a desperate location. Maez Waibel, a 29-year-old woman from Downinging, Pennsylvania, lost over 14 kilograms in just nine months thanks to Wegovy. But when the pharmacy was empty, she had to do without three months - and the weight came back. "You wonder: will that be my life?", Said Waibel.

bottlenecks and despair

The situation is alarming! Recurring bottlenecks and insufficient information about side effects force doctors and patients to experiment with doses and income cycles. Many patients juggle with their medication, depending on what is currently available. The prices are exorbitant-up to $ 1,000 per month without insurance! And while some medication such as Mounjaro and Zepbound are available in sufficient quantities, Wegovy often remains unreachable. The manufacturers fight to cover the exploding demand while the patients desperately search for solutions.

The bottlenecks show the weaknesses of the American health system and raise questions about the government's responsibility. Senator Bernie Sanders criticized the price differences between the USA and other countries, where the same medications are significantly cheaper. "It is frustrating that each country has its own health system," said Sanders. The pharmaceutical companies are under pressure to improve care, but reality remains chaotic and unpredictable.

a medication for life or a game with fate?

The idea behind these medication is simple: they should reduce hunger and extend the feeling of satiety. But reality looks different. A frightening number of patients breaks off treatment, often due to bottlenecks or high costs. A study shows that over 30 percent of patients give up after only four weeks! The confusion and uncertainty on the market mean that many patients give up frustrated or fall back on risky alternatives such as bariatric operations.

The situation is not only frustrating for the patients, but also for the doctors who have to fight with the unpredictable bottlenecks and the different inlation habits. "It is a cat-and-mouse game", a patient describes her desperate search for the medication. In the meantime, the question remains how the health system can deal with the growing number of overweight people who are dependent on these medication.